Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bicarbonate for contrast-induced kidney injury in advanced CKD (BOSS)
NCT00930436Phase 3Terminated
- Sponsor
- MD Scientific
- Start
- Jan 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium bicarbonate in contrast-induced acute kidney injury (CI-AKI), sponsored by MD Scientific. Started Jan 2010; status: terminated.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT00930436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930436.